FDA DEVICE FACTS
Refobacin Bone Cement R (110034355)
Biomet France
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Refobacin Bone Cement R is indicated to be used for stable anchoring of suitable joint prostheses to the bone, in hip and knee revision arthroplasty operations when reconstruction is necessary because of revision of previous arthroplasty procedures due to joint infection, also in case an infection with gentamicin-sensitive strains is a potential risk. Refobacin Bone Cement R is indicated to be used in the second stage of a two-stage revision for total joint arthroplasty after the initial infection has been cleared.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。